Type 2 diabetes: open trials in Ukraine

• NCT07900633

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Regional Communal Non-commercial enterprise "Chernivtsi regional clinical hospital", Chernivtsi · Clinical Diagnostic Center, Ivano-Frankivsk · Institute of Endocrinology and Metabolism named after Komissarenko, Kiev · ARTEM, Kyiv · Medbud Clinic, Kyiv · Edelweiss Medics, Kyiv · Lviv City Clinical Hospital #4, Lviv · Zakarpattia Endoclinic, Uzhhorod · Vinnytsia Regional Clinical Endocrinology Dispensary, Vinnytsia · "University Clinic" of Vinnytsia National Memorial Medical University n.a. M.I.Pyrohov (Treatment-educatio -T, Vinnytsia

  Registry updated 2026-11-03

• NCT07662109

  A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Kyiv · Lviv · Uzhhorod · Vinnytsia

  Registry updated 2026-10-30

• NCT07690163

  DIabetes GLycemic Assessment in Newly Confirmed Episodes

  Trial Treatment · Nazarii Kobyliak

  University Hospital of Bogomolets National Medical University, Kyiv · Bogomoletz Institute of Physiology, Kyiv · Bogomolets National Medical University, Kyiv

  Registry updated 2026-09-29

• NCT03549754

  iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

  Research · AstraZeneca

  Dnipro · Kharkiv · Kyiv · Lutsk · Uzhhorod · Vinnytsia · Zaporizhzhya

  Registry updated 2026-09-09

• NCT07662135

  A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

  Trial Treatment · Phase 3 · AstraZeneca

  Kyiv · Lviv · Vinnytsia

  Registry updated 2026-09-02

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error